MatchaDB

2023Article de revueAccès libre

Editorial: Women in gastrointestinal cancers, volume II: 2022

Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee

Frontiers in Oncology

Lire chez l'éditeur→Texte intégral gratuit→PubMed

Résumé

Women in Gastrointestinal Cancer Vol II: 2022 EDITORIAL This editorial presents the inaugural Frontiers in Oncology (FIO) 'Women in Gastrointestinal Cancer Vol II: 2022" series of article collections. The research topic collection highlights the diversity of research performed across the entire breadth of oncology research by women scientists pursuing STEM careers. Nine (9) research articles, from 14 submitted to FIO within this section, published under this research topic by 92 authors, aimed to present advances in theory, experiment, and methodology, with applications to compelling problems related to gastric cancers: gastrointestinal (GI) cancer: Hepato-Pancreatic Biliary (HPB) cancers. 1/9 is a brief research report article titled "the BET inhibitor JQ1 potentiates the anticlonogenic effect of radiation in pancreatic cancer cells". 1/9 is a case report article titled "a female with synchronous multiple primary malignant tumors in the esophagogastric junction, duodenum, and pancreas: Case report and review of the literature". Methodology Clinical trial article 1/9 under the title "implementing pharmacogenetic testing in gastrointestinal cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 screening to guide chemotherapy dosing". Four out of the nine (4/9) published articles are original research articles exploring the tumor-immune interactions in the tumor microenvironment (TME) and identifying new prognostic and/or therapeutic biomarkers to assist in novel decoding mechanism(s) of tumor immunotherapy as well as being confined with personalized treatment based on geno/pheno-typic evaluations. These four articles are, first "Evaluation of Galanin Expression in Colorectal Cancer (CRC): An Immunohistochemical (IHC)…

Résumé raccourci. Lire le résumé complet à la source.

Le texte du résumé provient de PubMed, OpenAlex ou Europe PMC et appartient aux auteurs et à l'éditeur.

Type d'étude

Revue systématique / méta-analyse

Une recherche structurée et une analyse combinée d'études antérieures.

Attribué automatiquement à partir du titre, du résumé et des termes de sujet.

Thèmes

Le matcha est ici un sujet principal (nommé dans les mots-clés).

Mots-clés et termes de sujet

Votre dossier de recherche

Citer cette étude

Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee. (2023). Editorial: Women in gastrointestinal cancers, volume II: 2022. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1192814

DOI : 10.3389/fonc.2023.1192814 · PubMed ID : 37265801

Plus sur Métabolisme et poids

2023Article de revue

Monitoring chlorophyll changes during Tencha processing using portable near-infrared spectroscopy.

Liu L, Zareef M, Wang Z, et al. — Food chemistry

Monitoring chlorophyll during Tencha (the raw ingredient for matcha) processing is critical for determining the matcha's color and quality. The purpose of this study is to explore the mechanism of chlorophyll changes during Tencha…

Chimie / analyseCulture et ombrageTransformation, mouture et qualitéAuthenticité et méthodes d'analyseCité 106 fois
2018Article de revueAccès libre

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

In vitro / étude cellulaireMétabolisme et poidsAntioxydants et polyphénolsCancerCité 75 fois
2020Article de revue

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJ, et al. — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

Étude animaleMétabolisme et poidsIntestin et microbiomeMarché, culture et durabilitéCité 74 fois

Parcourir toute la bibliothèque→